万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生3>>生物工程与应用微生物
您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生2>>遗传学
您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生3>>医学(研究与实验)

The Journal of Gene Medicine《基因医学杂志》 (官网投稿)

简介
  • 期刊简称J GENE MED
  • 参考译名《基因医学杂志》
  • 核心类别 SCIE(2023版), 目次收录(知网),外文期刊,
  • IF影响因子
  • 自引率1.00%
  • 主要研究方向医学-BIOTECHNOLOGY & APPLIED MICROBIOLOGY生物工程与应用微生物;GENETICS & HEREDITY遗传学;MEDICINE, RESEARCH & EXPERIMENTAL医学:研究与实验

主要研究方向:

等待设置主要研究方向
医学-BIOTECHNOLOGY & APPLIED MICROBIOLOGY生物工程与应用微生物;GENETICS & HEREDITY遗传学;MEDICINE, RESEARCH & EXPERIMENTAL医学:研究与实验

The Journal of Gene Medicine《基因医学杂志》(月刊). The aims and scope of The Journal of Gene Medicine include cutting-edge science of ...[显示全部]
征稿信息

万维提示:

1、投稿方式:在线投稿。

2、期刊网址:

https://onlinelibrary.wiley.com/journal/15212254

3、投稿网址:https://wiley.atyponrex.com/journal/JGM

4、官网邮箱:JGMedoffice@wiley.com

5、期刊刊期:月刊,一年出版12期。

2021年1029日星期五

                          

 

投稿须知【官网信息】

 

The Journal of Gene Medicine

Author Guidelines

For additional tools visit Author Resources - an enhanced suite of online tools for Wiley journal authors, featuring Article Tracking, E-mail Publication Alerts and Customized Research Tools.

1. SUBMISSION

Authors should kindly note that submission implies (i) that the content has not been published previously, in any language, in whole or in part, except as a brief abstract in the proceedings of a scientific meeting or symposium; (ii) that the manuscript is not currently under consideration for publication elsewhere; (iii) that all authors have read and approved the content of the manuscript; (iv) that all authors have declared all competing interests; and (v) that the work complies with Ethical Policies of the journal, and has been conducted under internationally accepted ethical standards after relevant ethical review.

By submitting a manuscript to or reviewing for this publication, your name, email address, and affiliation, and other contact details the publication might require, will be used for the regular operations of the publication, including, when necessary, sharing with the publisher (Wiley) and partners for production and publication. The publication and the publisher recognize the importance of protecting the personal information collected from users in the operation of these services, and have practices in place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data collected and processed. You can learn more at https://authorservices.wiley.com/statements/data-protection-policy.html

Once you have prepared your submission in accordance with the Guidelines, new submissions should be made via the Research Exchange submission portal https://wiley.atyponrex.com/journal/JGM. Should your manuscript proceed to the revision stage, you will be directed to make your revisions via the same submission portal. For technical help with the submission system, please review our FAQs or contact submissionhelp@wiley.com.

For all submission enquiries please contact the editorial office - Email: JGMedoffice@wiley.com.

PEER REVIEW PROCESS

Rapid peer review: Journal of Gene Medicine is committed to rapid publication of articles. It is the intention of the Editorial Office to peer review manuscripts and notify authors of the decision within four weeks. The full text of the accepted version is then published online via 'Accepted Articles' within 7 days of acceptance, prior to going through the production process. After production the final PDF version of the article will be published and the accepted version removed.

Revised manuscripts should be submitted within three months of receiving the Editors’ decision, using the ‘create a revision’ option for the initial manuscript. Revised submissions should be accompanied by a letter specifying point-by-point how the author has responded to the reviewers’ and Editors’ comments.

2. AIMS AND SCOPE

Journal of Gene Medicine publishes cutting-edge science of gene transfer and its applications in gene and cell therapy, genome editing with precision nucleases, epigenetic modifications of host genome by small molecules, siRNA, microRNA and other noncoding RNAs as therapeutic gene-modulating agents or targets, biomarkers for precision medicine, and gene-based prognostic/diagnostic studies.

Key areas of interest are the design of novel synthetic and viral vectors, novel therapeutic nucleic acids such as mRNA, modified microRNAs and siRNAs, antagomirs, aptamers, antisense and exon-skipping agents, refined genome editing tools using nucleic acid /protein combinations, physically or biologically targeted delivery and gene modulation, ex vivo or in vivo pharmacological studies including animal models, and human clinical trials.

Papers presenting research into the mechanisms underlying transfer and action of gene medicines, the application of the new technologies for stem cell modification or nucleic acid based vaccines, the identification of new genetic or epigenetic variations as biomarkers to direct precision medicine, and the preclinical/clinical development of gene/expression signatures indicative of diagnosis or predictive of prognosis are also encouraged.

3. MANUSCRIPT CATEGORIES AND REQUIREMENTS

The journal publishes Editorial, Commentary, Research Article, Review Article, Letter to the Editor and Correspondence.

Review article is typically by invitation only, however proposals are welcome and may be accepted after editorial approval. Please contact the Editorial Office with your proposal before submitting a review article.

Letter to the Editor and Correspondence should be kept brief, and be written in clear and balanced language, to allow healthy scientific discourse to take place.

4. PREPARING THE SUBMISSION

Abbreviations are not encouraged except for units of measurement and universally recognized abbreviations (e.g. DNA). When an abbreviation appears in the text for the first time, it should be placed in parentheses after the words for which it stands.

Format. The main text file should be prepared using Microsoft Word using 1.5 line spacing.

Parts of the Manuscript

The text file should be presented in the following order: title page, abstract, keywords, main text, acknowledgments, conflict of interest statement, references, tables and figure legends. Figures and supporting information should be submitted in separate files.

Title page

The title page should contain:

(i) A short informative title containing the major key words. The title should not contain abbreviations (see Wiley's best practice SEO tips);

(ii) A short running title of no more than 40 characters, including spaces;

(iii) The full name of the authors (refer to the journal's Authorship policy in the Editorial Policies and Ethical Considerations section for details on author listing eligibility); and

(iv) The author's institutional affiliations where the work was conducted.

The present address of any author, if different from where the work was carried out, should be supplied in a footnote.

……

更多详情:

https://onlinelibrary.wiley.com/page/journal/15212254/homepage/forauthors.html


  • 万维QQ投稿交流群    招募志愿者

    版权所有 Copyright@2009-2015豫ICP证合字09037080号

     纯自助论文投稿平台    E-mail:eshukan@163.com


投稿问答最小化  关闭